• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    56 Biggest Movers From Yesterday

    12/10/21 4:16:37 AM ET
    $AVCT
    $AWRE
    $BITF
    $BKKT
    EDP Services
    Technology
    Computer Software: Prepackaged Software
    Technology
    Get the next $AVCT alert in real time by email

    Gainers

    • Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ:IINN) shares jumped 84% to close at $4.95 on Thursday after the company signed an exclusive summary distribution agreement with Innovimed Sp. z o.o, a master distributor specializing in medical solutions in Eastern Europe, the Middle East, and Africa.
    • American Virtual Cloud Technologies, Inc. (NASDAQ:AVCT) jumped 82.5% to close at $1.88 after the company said it expects revenues of its Kandy Business Unit to increase from $14.3 million in 2020 to around $18.8 million in 2021 and in excess of $37 million in 2022.
    • Ensysce Biosciences, Inc. (NASDAQ:ENSC) jumped 66.8% to close at $4.97. Ensysce Biosciences shares jumped 136% on Tuesday after Zacks Small-Cap Research set a $23 valuation on the stock.
    • Boxed, Inc. (NYSE:BOXD) climbed 31.4% to close at $11.93 after the company said it will further integrate with Google Cloud to power global platform technology solutions.
    • Context Therapeutics Inc. (NASDAQ:CNTX) surged 24.2% to settle at $6.26
    • Insignia Systems, Inc. (NASDAQ:ISIG) gained 23% to settle at $23.50 after climbing more than 84% on Wednesday. Insignia Systems recently announced the commencement of a formal process to explore strategic options to maximize shareholder value, including potential merger or acquisition.
    • HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) rose 20.9% to close at $4.10 after the company announced it has exceeded $1 million in sales of its HTC Transcriptome Panel.
    • Huadi International Group Co., Ltd. (NASDAQ:HUDI) gained 20.2% to settle at $27.65.
    • Kanzhun Limited (NASDAQ:BZ) gained 19.1% to close at $36.51.
    • Jasper Therapeutics, Inc. (NASDAQ:JSPR) jumped 17.8% to settle at $9.99.
    • MeaTech 3D Ltd. (NASDAQ:MITC) gained 17.7% to close at $8.97.
    • iPower Inc. (NASDAQ:IPW) surged 16.1% to settle at $3.32 after the company announced the launch of its new "Flourish" line of advanced nutrient products, now available on Amazon.
    • Ciena Corporation (NYSE:CIEN) jumped 15.6% to close at $71.93 after the company reported better-than-expected Q4 sales results and announced a $1 billion buyback.
    • Nu Holdings Ltd. (NYSE:NU) jumped 14.8% to settle at $10.33 after the company priced its IPO at $9 per share.
    • Cadre Holdings, Inc. (NYSE:CDRE) surged 14.4% to close at $20.60.
    • Hovnanian Enterprises, Inc. (NYSE:HOV) gained 14.3% to close at $122.96 after the company reported Q4 EPS and sales results increased year over year and issued Q1, Q2 and FY22 sales guidance.
    • Verona Pharma plc (NASDAQ:VRNA) surged 14% to settle at $4.56.
    • Aware, Inc. (NASDAQ:AWRE) gained 13.9% to close at $3.44.
    • Mainz Biomed B.V. (NASDAQ:MYNZ) rose 12.8% to settle at $9.70.
    • Wallbox N.V. (NYSE:WBX) gained 12.7% to close at $14.77.
    • Recruiter.com Group, Inc. (NASDAQ:RCRT) rose 11.4% to close at $4.19. Maxim Group initiated coverage on Recruiter.Com Group with a Buy rating and announced a price target of $9.
    • Lee Enterprises, Incorporated (NYSE:LEE) rose 11%to close at $27.70 after reporting Q4 results. The company’s board unanimously rejected unsolicited proposal from Alden.
    • Wejo Group Limited (NASDAQ:WEJO) rose 10.7% to close at $7.26.
    • NextNav Inc. (NASDAQ:NN) jumped 10.1% to close at $7.94.
    • RH (NYSE:RH) gained 5.5% to close at $608.51 after the company reported better-than-expected Q3 EPS and sales results and raised the low end of FY21 sales guidance.
    • Stitch Fix, Inc. (NASDAQ:SFIX) rose 5.5% to close at $20.05. Stitch Fix earlier issued Q2 net sales guidance below estimates.
    • Nuvei Corporation (NASDAQ:NVEI) rose 4.8% to close at $60.76. Nuvei reaffirmed its FY21 guidance.


    Check out these big penny stock gainers and losers

    Losers

    • Renren Inc. (NYSE:RENN) shares tumbled 53.4% to close at $12.15 on Thursday. Renren will hold its Annual General Meeting of Shareholders on December 17, 2021.
    • Reata Pharmaceuticals, Inc. (NASDAQ:RETA) dropped 46.5% to close at $29.11. The FDA's Cardiovascular and Renal Drugs Advisory Committee voted that the agency should not approve Reata Pharmaceuticals’ bardoxolone methyl capsules to slow the progression of chronic kidney disease in those with the rare Alport syndrome. Goldman Sachs downgraded Reata Pharmaceuticals from Buy to Neutral.
    • Tecnoglass Inc. (NASDAQ:TGLS) fell 36% to settle at $21.56 after Hindenburg Research issued a bearish report on the company.
    • NeuroSense Therapeutics Ltd. (NASDAQ:NRSN) dipped 32.6% to close at $4.04 after the company priced its IPO at $6 per share.
    • Code Chain New Continent Limited (NASDAQ:CCNC) fell 29.4% to close at $1.20 after jumping more than 20% on Wednesday.
    • Torrid Holdings Inc. (NASDAQ:CURV) fell 27.9% to settle at $11.28 after the company reported mixed Q3 earnings results and issued Q4 and FY21 net sales guidance below estimates.
    • BuzzFeed, Inc. (NASDAQ:BZFD) dropped 23.6% to close at $5.87.
    • Triterras, Inc. (NASDAQ:TRIT) shares fell 22.5% to close at $3.42 after the company issued further update on Independent Audit of financials for fiscal year ended Feb. 28, 2021.
    • Phreesia, Inc. (NYSE:PHR) dipped 21.2% to close at $42.56 after the company reported Q3 EPS results were lower year over year.
    • Beyond Air, Inc. (NASDAQ:XAIR) fell 20.5% to close at $8.44 after the company said, based on communication with the FDA, it no longer believes that the U.S. commercial launch of LungFit PH will take place prior to December 31, 2021.
    • Quantum Computing, Inc. (NASDAQ:QUBT) dipped 19.5% to close at $4.30.
    • IceCure Medical Ltd (NASDAQ:ICCM) fell 19.4% to close at $3.45. IceCure Medical priced 3,313,827 share offering at $3.45 per share.
    • Lucid Group, Inc. (NASDAQ:LCID) dipped 18.3% to close at $36.52 after the company reported a proposed convertible senior notes offering.
    • Perma-Pipe International Holdings, Inc. (NASDAQ:PPIH) fell 17.6% to settle at $7.32. Perma-Pipe Inlt posted Q3 EPS of $0.06.
    • IsoPlexis Corporation (NASDAQ:ISO) fell 17.4% to settle at $7.10.
    • Better Therapeutics, Inc. (NASDAQ:BTTX) declined 16.8% to close at $5.89.
    • Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) dropped 16.6% to settle at $4.82.
    • Mogo Inc. (NASDAQ:MOGO) fell 16% to close at $3.95 after the company announced a $27.5 million registered direct offering.
    • Imperial Petroleum Inc. (NASDAQ:IMPP) dropped 15.8% to settle at $2.71.
    • Zymeworks Inc. (NYSE:ZYME) fell 14.9% to settle at $16.12. The company announced new clinical data for the HER2-targeted bispecific antibody, zanidatamab, in heavily pretreated HER2-positive breast cancer.
    • Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) dipped 14.8% to close at $14.56 after the company announced the withdrawal of an EMA Marketing Authorization Application for obeticholic acid for advanced liver fibrosis due to NASH.
    • Terns Pharmaceuticals, Inc. (NASDAQ:TERN) fell 14.8% to close at $6.51.
    • Phunware, Inc. (NASDAQ:PHUN) declined 14.6% to settle at $3.34 after surging 21% on Wednesday.
    • Bakkt Holdings, Inc. (NYSE:BKKT) fell 14.4% to close at $14.68 after surging around 30% on Wednesday.
    • RingCentral, Inc. (NYSE:RNG) fell 13.2% to close at $186.21 after Deutsche Bank maintained a Buy rating and lowered its price target on the stock from $400 to $300.
    • Mawson Infrastructure Group, Inc. (NASDAQ:MIGI) fell 11% to close at $6.07.
    • Bitfarms Ltd. (NASDAQ:BITF) fell 9.6% to close at $5.81. Bitfarms named Geoff Morphy as Chief Operating Officer and announced grants of options.
    • LegalZoom.com, Inc. (NASDAQ:LZ) fell 9% to settle at $16.37.
    • Hooker Furnishings Corporation (NASDAQ:HOFT) dropped 8.6% to close at $23.19 after the company reported worse-than-expected Q3 EPS results.
    Get the next $AVCT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AVCT
    $AWRE
    $BITF
    $BKKT

    CompanyDatePrice TargetRatingAnalyst
    Quantum Computing Inc.
    $QUBT
    4/20/2026$20.00Outperform
    Northland Capital
    NextNav Inc.
    $NN
    4/16/2026$25.00Perform → Outperform
    Oppenheimer
    Hovnanian Enterprises Inc.
    $HOV
    4/9/2026$74.00Mkt Underperform
    Citizens
    Phreesia Inc.
    $PHR
    4/1/2026Mkt Outperform → Mkt Perform
    Citizens
    Phreesia Inc.
    $PHR
    3/31/2026$10.00Outperform → Neutral
    Robert W. Baird
    Phreesia Inc.
    $PHR
    3/31/2026$11.00Buy → Hold
    Truist
    Phreesia Inc.
    $PHR
    3/31/2026$10.00Buy → Neutral
    Citigroup
    Phreesia Inc.
    $PHR
    3/31/2026$16.00Overweight → Neutral
    Analyst
    More analyst ratings

    $AVCT
    $AWRE
    $BITF
    $BKKT
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for SKYCLARYS issued to REATA PHARMACEUTICALS INC

    Submission status for REATA PHARMACEUTICALS INC's drug SKYCLARYS (ORIG-1) with active ingredient OMAVELOXOLONE has changed to 'Approval' on 02/28/2023. Application Category: NDA, Application Number: 216718, Application Classification: Type 1 - New Molecular Entity

    2/28/23 5:14:09 PM ET
    $RETA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    July 1, 2022 - FDA Roundup: July 1, 2022

    For Immediate Release: July 01, 2022 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA announced a request for nominations for consumer representatives to serve on advisory committees and panels for which vacancies currently exist or are expected to occur in the near future. The FDA relies on our many advisory committees to help us

    7/1/22 11:54:25 AM ET
    $XAIR
    Medical/Dental Instruments
    Health Care

    FDA Approval for OCALIVA issued to INTERCEPT PHARMS INC

    Submission status for INTERCEPT PHARMS INC's drug OCALIVA (SUPPL-8) with active ingredient OBETICHOLIC ACID has changed to 'Approval' on 02/24/2022. Application Category: NDA, Application Number: 207999, Application Classification: Labeling

    2/25/22 4:36:46 AM ET
    $ICPT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AVCT
    $AWRE
    $BITF
    $BKKT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Traverse David K bought $5,175 worth of shares (4,500 units at $1.15), increasing direct ownership by 8% to 60,984 units (SEC Form 4)

    4 - AWARE INC /MA/ (0001015739) (Issuer)

    3/17/26 5:24:55 PM ET
    $AWRE
    Computer Software: Prepackaged Software
    Technology

    Director Stafford John S Iii bought $21,445 worth of shares (16,754 units at $1.28), increasing direct ownership by 0.33% to 5,121,954 units (SEC Form 4)

    4 - AWARE INC /MA/ (0001015739) (Issuer)

    3/17/26 5:15:34 PM ET
    $AWRE
    Computer Software: Prepackaged Software
    Technology

    Large owner Energy Holding Corp bought $9,727,810 worth of Ordinary Shares (215,229 units at $45.20), increasing direct ownership by 1% to 20,731,985 units (SEC Form 4)

    4 - Tecnoglass Inc. (0001534675) (Issuer)

    3/16/26 4:58:07 PM ET
    $TGLS
    Electronic Components
    Consumer Discretionary

    $AVCT
    $AWRE
    $BITF
    $BKKT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Rozanovich Yoav

    3 - Inspira Technologies OXY B.H.N. Ltd (0001837493) (Issuer)

    4/23/26 7:45:16 AM ET
    $IINN
    Medical/Dental Instruments
    Health Care

    SEC Form 4 filed by Arora Tarun

    4 - RingCentral, Inc. (0001384905) (Issuer)

    4/22/26 6:24:06 PM ET
    $RNG
    EDP Services
    Technology

    SEC Form 4 filed by Hui Yvonne

    4 - Phreesia, Inc. (0001412408) (Issuer)

    4/21/26 4:36:45 PM ET
    $PHR
    Real Estate

    $AVCT
    $AWRE
    $BITF
    $BKKT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Northland Capital initiated coverage on Quantum Computing with a new price target

    Northland Capital initiated coverage of Quantum Computing with a rating of Outperform and set a new price target of $20.00

    4/20/26 8:28:07 AM ET
    $QUBT
    Computer Software: Prepackaged Software
    Technology

    NextNav upgraded by Oppenheimer with a new price target

    Oppenheimer upgraded NextNav from Perform to Outperform and set a new price target of $25.00

    4/16/26 7:59:04 AM ET
    $NN
    Industrial Machinery/Components
    Industrials

    Citizens initiated coverage on Hovnanian with a new price target

    Citizens initiated coverage of Hovnanian with a rating of Mkt Underperform and set a new price target of $74.00

    4/9/26 8:42:51 AM ET
    $HOV
    Homebuilding
    Consumer Discretionary

    $AVCT
    $AWRE
    $BITF
    $BKKT
    SEC Filings

    View All

    Cumberland Pharmaceuticals Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Filer)

    4/24/26 5:08:24 PM ET
    $CPIX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Lee Enterprises Incorporated filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - LEE ENTERPRISES, Inc (0000058361) (Filer)

    4/24/26 4:47:47 PM ET
    $LEE
    Newspapers/Magazines
    Consumer Discretionary

    SEC Form PRE 14A filed by Beyond Air Inc.

    PRE 14A - Beyond Air, Inc. (0001641631) (Filer)

    4/24/26 4:30:11 PM ET
    $XAIR
    Medical/Dental Instruments
    Health Care

    $AVCT
    $AWRE
    $BITF
    $BKKT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Lee Enterprises, Inc. Names Chief Executive and Chief Financial Officers

    DAVENPORT, Iowa, April 24, 2026 (GLOBE NEWSWIRE) -- Nathan Bekke, President and Interim Chief Executive Officer, has been named President and Chief Executive Officer of Lee Enterprises, Incorporated (NASDAQ:LEE). Concurrently, Josh Rinehults, Vice President, Interim Chief Financial Officer and Treasurer, has been named Vice President, Chief Financial Officer and Treasurer. The Board of Directors unanimously approved both appointments. Bekke and Rinehults have served in their interim roles since the closing of the company's strategic investment in February 2026. David Hoffmann, Chairman of Lee's Board of Directors, said "Following a comprehensive nationwide search, the Board is confident t

    4/24/26 4:00:00 PM ET
    $LEE
    Newspapers/Magazines
    Consumer Discretionary

    Merck Announces Expiration of Hart-Scott-Rodino Act Waiting Period to Acquire Terns Pharmaceuticals, Inc.

    Merck (NYSE:MRK), known as MSD outside of the United States and Canada, today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR"), in connection with Merck's pending acquisition of Terns Pharmaceuticals, Inc. ("Terns") (NASDAQ:TERN) expired at 11:59 p.m., Eastern Time, on April 23, 2026. As previously announced on April 7, 2026, Merck commenced, through a subsidiary, a cash tender offer to purchase all outstanding shares of common stock of Terns, for $53.00 net in cash for each share of Terns common stock validly tendered and not validly withdrawn in the offer, without interest and less any applicable tax withholding. The ex

    4/24/26 6:45:00 AM ET
    $MRK
    $TERN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    BOSS Zhipin's Ongoing Share Repurchases Cross the RMB1 Billion Mark in 2026

    BEIJING, April 24, 2026 (GLOBE NEWSWIRE) -- KANZHUN LIMITED ("BOSS Zhipin" or the "Company") (NASDAQ:BZ, HK: 2076)) today announced the continued execution of its share repurchase program, utilizing over RMB27.3 million to repurchase 597,224 ordinary shares on April 23. With this latest repurchase, the Company has deployed over RMB1 billion toward share repurchases year-to-date in 2026. This effort underscores the Company's ongoing commitment to delivering value to shareholders. CONTACT: PIACENTE FINANCIAL COMMUNICATIONS [email protected]

    4/24/26 6:30:00 AM ET
    $BZ
    Computer Software: Programming Data Processing
    Technology

    $AVCT
    $AWRE
    $BITF
    $BKKT
    Leadership Updates

    Live Leadership Updates

    View All

    Inspira Technologies Appoints Yoav Rozanovich as Chief Business Officer to Drive Immediate Revenue Growth and Quantum Expansion

    RA'ANANA, Israel, April 14, 2026 (GLOBE NEWSWIRE) -- Inspira Technologies OXY B.H.N. Ltd (NASDAQ:IINN, IINNW)) ("Inspira Technologies" or the "Company") today announced the appointment of Mr. Yoav Rozanovich as Chief Business Officer ("CBO") of Inspira Technologies, reinforcing its commercial execution capabilities following its expansion into quantum computing connectivity and the acquisition of the Additive Manufacturing of Electronics ("AME") business from Nano Dimension Ltd. (NASDAQ:NNDM) ("Nano Dimension"). Proven Commercial LeadershipMr. Rozanovich brings international experience across additive manufacturing, advanced electronics, and complex systems integration. From November 2021

    4/14/26 8:01:00 AM ET
    $IINN
    $NNDM
    $SSYS
    Medical/Dental Instruments
    Health Care
    Electrical Products
    Technology

    Lucid Names Global Industrial Leader Silvio Napoli as Next Chief Executive Officer to Accelerate Growth, Profitability and Value Creation

    Silvio Napoli, formerly Chairman and Chief Executive Officer of Schindler Group, to join Lucid as next Chief Executive OfficerInterim Chief Executive Officer Marc Winterhoff will continue as Chief Operating Officer upon Napoli assuming the roleNEWARK, Calif., April 14, 2026 /PRNewswire/ -- Lucid Group, Inc. (NASDAQ:LCID), maker of the world's most advanced software-defined vehicles and technologies, today announced that Silvio Napoli will be Lucid's next Chief Executive Officer (CEO) and will join Lucid's Board of Directors. Mr. Napoli is currently based in Switzerland and will be relocating to the U.S. Interim Chief Executive Officer Marc Winterhoff will serve as Lucid's Chief Operating Off

    4/14/26 7:00:00 AM ET
    $LCID
    Auto Manufacturing
    Industrials

    Zymeworks Announces Additional Leadership Appointments to Advance Next Phase of Growth

    • Adam Schayowitz, Ph.D., MBA appointed as Head of R&D• Scott Platshon appointed as Chief Business Officer  VANCOUVER, British Columbia, April 09, 2026 (GLOBE NEWSWIRE) -- Zymeworks Inc. (NASDAQ:ZYME), a biotechnology company managing a portfolio of licensed healthcare assets, while developing a diverse pipeline of novel, multifunctional biotherapeutics, today announced the full-time appointments of Dr. Adam Schayowitz and Mr. Scott Platshon as of April 9, 2026, from their previously interim roles. Both Dr. Schayowitz and Mr. Platshon will report directly to Kenneth Galbraith, Chair and Chief Executive Officer of Zymeworks. "These appointments come at a pivotal time for Zymeworks as we e

    4/9/26 6:00:00 AM ET
    $ZYME
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AVCT
    $AWRE
    $BITF
    $BKKT
    Financials

    Live finance-specific insights

    View All

    Lee Enterprises plans quarterly call and webcast May 7, 2026

    DAVENPORT, Iowa, April 23, 2026 (GLOBE NEWSWIRE) -- Lee Enterprises, Incorporated (NASDAQ:LEE), a major subscription and advertising platform and a leading provider of high quality, trusted, local news and information in 72 markets, has scheduled an audio webcast and conference call for Thursday, May 7, 2026, at 9 a.m. Central Time. Lee plans to issue a news release before the market opens that day with preliminary results for its quarter ended March 29, 2026. A live webcast of the conference call may be accessed via the Investor Relations portion of Lee's website or here. To participate in the live conference call via telephone, please register here. Upon registering, a dial-in number an

    4/23/26 11:00:00 AM ET
    $LEE
    Newspapers/Magazines
    Consumer Discretionary

    Cadre Holdings Declares Quarterly Dividend of $0.10 Per Share

    Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, today announced that its Board of Directors has declared a quarterly cash dividend of $0.10 per share, or $0.40 per share on an annualized basis. Cadre's dividend payment will be made on May 15, 2026 to shareholders of record as of the close of business on the record date of May 1, 2026. The declaration of any future dividend is subject to the discretion of the Company's Board of Directors. About Cadre Headquartered in Jacksonville, Florida, Cadre is a global

    4/21/26 4:15:00 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    IceCure Participates in Society of Breast Imaging Symposium 2026 as U.S. ProSense® Revenue Increases by 30%+ in First Quarter of 2026 Compared to First Quarter of 2025

    The Company's participation at the Society of Breast Imaging Symposium and other upcoming medical conferences are timely as commercial momentum acceleratesCryoablation cost analysis study from Massachusetts General Hospital featuring ProSense® demonstrated 50% reduction in cost vs. lumpectomy won SBI 2026 Abstract AwardCAESAREA, Israel, April 21, 2026 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ:ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an option to surgical tumor removal, today announced that it expects to report U.S. revenue of ProSense® systems and cryoprobes increased more than 30% in

    4/21/26 8:30:00 AM ET
    $ICCM
    Medical/Dental Instruments
    Health Care

    $AVCT
    $AWRE
    $BITF
    $BKKT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Torrid Holdings Inc.

    SC 13G - Torrid Holdings Inc. (0001792781) (Subject)

    12/12/24 6:06:52 PM ET
    $CURV
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    SEC Form SC 13G filed by NeuroSense Therapeutics Ltd.

    SC 13G - NeuroSense Therapeutics Ltd. (0001875091) (Subject)

    12/9/24 4:00:18 PM ET
    $NRSN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by NextNav Inc.

    SC 13D/A - NEXTNAV INC. (0001865631) (Subject)

    12/6/24 6:03:25 PM ET
    $NN
    Industrial Machinery/Components
    Industrials